Cancer Immunotherapy: Bridging Basic Research and Clinical Translation (A1)
      
      
      
      
      
      January 24-27, 2027
       | Beaver Run Conference Center, Breckenridge, CO, United States
      
      
      
         
          Ana Carrizosa Anderson, Drew M. Pardoll, Neta Erez and Ivan Diaz-Padilla
        
            
      
      
      
          
      
   
            
     
          
    
      
      
        
        
      
        
      
  
      
      
        
                
        
      
      
    
        
      
        
      
  
      
      
        
                
        
      
      
    
        
      
        
      
  
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 4:00–8:00 PM | 
            Registration | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 6:00–8:00 PM | 
            Welcome Mixer | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
        
      
        
      
  
      
      
        
                
        
      
      
    
      
           
      
  
        
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 8:00–9:00 AM | 
            Welcome and Keynote Address | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Antoni Ribas, University of California, Los Angeles How Tumors Enable Immunotherapy | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
        
        
          
            | 9:00–11:15 AM | 
            Reimagining Checkpoint Targeted Therapies | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Ivan Diaz-Padilla, Ipsen, Oncology Global Research & Development Lessons from Checkpoint Blockade Trials | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Andrea Cercek, Memorial Sloan Kettering Cancer Center Neoadjuvant Checkpoint Blockade in MMRd Cancer | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Drew M. Pardoll, Johns Hopkins University School of Medicine Understanding Resistance to Checkpoint Inhibition based on Neoadjuvant Clinical Trials | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Short Talk(s) Chosen from Abstracts
  | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
        
        
          
            | 9:30–9:50 AM | 
            Coffee Break | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 11:15–12:15 PM | 
            Panel Discussion: Circadian Control of Immunotherapy | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 11:15–1:00 PM | 
            Poster Setup | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 11:15–5:00 PM | 
            On Own for Lunch | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 1:00–10:00 PM | 
            Poster Viewing | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 2:30–4:30 PM | 
            Symposia Spotlight 1: Cancer-Neuroimmunology | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Short Talks Chosen from Abstracts
  | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
        
        
          
            | 4:30–5:00 PM | 
            Coffee Available | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 5:00–7:00 PM | 
            Biological Insights from Systems that Model Human Cancer | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Daniela Thommen, Netherlands Cancer Institute Rewiring T Cells in PD1 Resistant Tumors | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Neta Erez, Weizmann Institute of Science Stromal and Immune Plasticity Shape the Metastatic Niche | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Raza Ali, University of Cambridge Systems Cancer Pathology | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Short Talk(s) Chosen from Abstracts
  | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
        
        
          
            | 7:00–8:00 PM | 
            Social Hour with Dinner | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
        
      
      
        
                
        
      
      
    
      
        
          
            Tuesday, January 26, 2027
          
           
         
      
        
      
  
      
      
        
                
        
      
      
    
      
           
      
  
        
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 8:00–11:00 AM | 
            Harnessing Innate Cells for Cancer Therapy | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Eric Vivier, Aix Marseille University and Innate Pharma Harnessing NK Cells in Cancer Therapies | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Lydia Lynch †, Princeton University Targeting Innate T Cells in Cancer (MAIT , gdT, and iNKT) | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Judith A. Varner, University of California, San Diego Macrophage Directed Immunotherapies | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Marco Colonna †, Washington University School of Medicine Trem2 based Therapies in Cancer | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Short Talk(s) Chosen from Abstracts
  | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
        
        
          
            | 9:00–9:20 AM | 
            Coffee Break | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 11:00–1:00 PM | 
            Poster Setup | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 11:00–5:00 PM | 
            On Own for Lunch | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 1:00–10:00 PM | 
            Poster Viewing | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 3:00–4:30 PM | 
            Career Roundtable | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 4:30–5:00 PM | 
            Coffee Available | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 5:00–7:00 PM | 
            Mechanisms Shaping T Cell Differentiation in Cancer | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Mary Philip, Vanderbilt University Medical Center Early CD8+ T Cell Fate Commitment in Cancer | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Ana Carrizosa Anderson, Harvard Medical School Talk Title to be Announced | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Jean-Christophe Beltra, University of Basel Cytokine-Directed Gene Programs Shaping CD8+ T Cell Differentiation in Cancer | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Short Talk(s) Chosen from Abstracts
  | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
        
        
          
            | 7:00–8:00 PM | 
            Social Hour with Dinner | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
        
      
      
        
                
        
      
      
    
      
        
          
            Wednesday, January 27, 2027
          
           
         
      
        
      
  
      
      
        
                
        
      
      
    
      
           
      
  
        
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 8:00–11:00 AM | 
            Applying Engineering and Materials Science to Cancer Immunotherapy | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            David J. Mooney, Harvard University Engineering T Cell Cancer Therapies | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Naimish Patel †, CRISPR Therapeutics Therapeutic Applications of CRISPR | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Peter Benedict Kirk †, Immunocore Bi-Specific T Cell Engagers (BiTes) | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Jamie Spangler, Johns Hopkins University Engineering Proteins for Immunotherapy | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Short Talk(s) Chosen from Abstracts
  | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
        
        
          
            | 9:00–9:20 AM | 
            Coffee Break | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 11:00–5:00 PM | 
            On Own for Lunch | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 2:30–4:30 PM | 
            Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Short Talks Chosen from Abstracts
  | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
        
        
          
            | 4:30–5:00 PM | 
            Coffee Available | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 5:00–6:45 PM | 
            Pushing the Envelope in Cancer Vaccines: Generation and Application | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Yardena Samuels, Weizmann Institute of Science Novel Mechanisms Producing Targetable Tumor Antigens | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Eduardo Vilar-Sanchez, University of Texas MD Anderson Cancer Center Cancer Vaccines for Immunoprevention | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Özlem Türeci †, BioNTech Next Generation Cancer Vaccines | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
      
  
      
      
        
        
        
        
          
            |   | 
            Short Talk(s) Chosen from Abstracts
  | 
              | 
          
        
        
                
        
       
      
    
      
           
      
  
      
        
        
        
          
            | 6:45–7:00 PM | 
            Meeting Wrap-Up: Outcomes and Future Directions (Organizers) | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 7:00–8:00 PM | 
            Social Hour with Dinner | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
      
        
        
        
          
            | 8:00–11:00 PM | 
            Entertainment | 
             | 
          
        
        
        
         
      
      
        
                
        
      
      
    
      
           
      
  
        
      
      
        
                
        
      
      
    
      
        
          
            Thursday, January 28, 2027